All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy
  TRANSLATE

The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

Key challenges and best practice recommendations in pregnant patients with MPN

Jul 5, 2022
Share:
Learning objective: After reading this article, learners will be able to cite a new development in rare MPN and MPN in special populations.

The MPN Hub was pleased to speak to Claire Harrison, Guy's and St Thomas' NHS Foundation Trust, London, UK. We asked, what are the key challenges and best practice recommendations in pregnant patients with myelodysplastic syndromes (MPN)?

Key challenges and best practice recommendations in pregnant patients with MPN

Harrison begins by discussing why pregnancy can cause problems in patients with MPN, and which types of MPN are most common in these patients. Harrison also discusses the importance of planning pregnancy in advance, and the use of anticoagulants.

More about...